13FCATALYST PHARMACEUTICALS INC (CPRX)
7 tracked managers currently hold CPRX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | Q2 2026 | TRIM | $67.1M | 0.1 % | 0.1 % | 2,136,077 | -211,400 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | ADD | $33.6M | 0.0 % | 0.0 % | 1,068,724 | +301,733 |
| SOROS FUND MANAGEMENT LLC | Q2 2026 | NEW | $10.8M | 0.1 % | — | 344,593 | NEW |
| Point72 Asset Management, L.P. | Q2 2026 | TRIM | $5.5M | 0.0 % | 0.0 % | 176,560 | -249,305 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $4.2M | 0.0 % | 0.0 % | 134,531 | +93,989 |
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $2.7M | 0.0 % | 0.0 % | 85,147 | -495,946 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | NEW | $954.0K | 0.0 % | — | 30,354 | NEW |